Advertisement
Research Updates

Disparities

  • Getting a Read on Cancer

    Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.

    by Kate Yandell

  • Reinforcements for Cancer Research

    Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.

    by Marci A. Landsmann

  • Does Medicaid Expansion Have an Impact?

    Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.

    by Marci A. Landsmann

  • Achieving Health Equality

    National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.

    by Marci A. Landsmann

  • The Roots of Rural Health Disparities

    New research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.

    by Cheryl Platzman Weinstock

  • A New Guideline for Cervical Cancer Screening

    Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.

    by Anna Azvolinsky

  • Forward Look

    Lung Cancer Biology Differs by Race, Study Shows

    Research findings could help improve personalized treatments for lung cancer patients.

    by Stephen Ornes

  • Policy Matters

    Putting an End to Cancer Health Disparities

    Cancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.

    by Michael A. Caligiuri, MD

  • Forward Look

    Opening Clinical Trials to HIV-Positive Cancer Patients

    Including patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.

    by Andy Kopsa

  • Omitting Obesity

    Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.

    by Cici Zhang